AgomAb Therapeutics NV

AGMB

$14.32

Today

as of Aug 5, 16:45 ET

Last 30 days -19.64% Jun 29 → Aug 05

Open

—

High

—

Low

—

Volume

—

Avg Vol

—

Mkt Cap

$639M

P/E (TTM)

—

Beta

—

52w High

—

52w Low

—

Div Yield

—

Shares Out

—

Recent Press Releases & News last 60 days · 4 items

Jul 23 · 12:22 MT Newswires

B. Riley Initiates AgomAb Therapeutics at Buy With $34 Price Target

Jul 2 · 20:06 Insider Monkey

Is AgomAB Therapeutics NV (AGMB) Stock a Biotech Opportunity With Targeted Tissue Therapy Potential?

Jun 23 · 21:32 MT Newswires

Agomab Therapeutics Shares NOV-ERA Phase 2b Study Design With Ontunisertib in Fibrostenosing Crohn's Disease

▸ Show all 4 press releases & news Free account →

Overview

52-week range

—

Avg surprise (last 0)

—

Avg reaction (last 0)

—

Earnings trends

Implied volatility — last 90 days

No IV snapshots yet for AGMB.

IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.

View on Nasdaq ↗